{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:51:54Z","timestamp":1758639114530},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.nucmedbio.2013.05.007","type":"journal-article","created":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T10:46:28Z","timestamp":1372329988000},"page":"747-754","source":"Crossref","is-referenced-by-count":7,"title":["Radiosynthesis and evaluation of new \u03b11-adrenoceptor antagonists as PET radioligands for brain imaging"],"prefix":"10.1016","volume":"40","author":[{"given":"Anu J.","family":"Airaksinen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sjoerd J.","family":"Finnema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Balle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"Varn\u00e4s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benny","family":"Bang-Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bal\u00e1zs","family":"Guly\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Farde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christer","family":"Halldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0005","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.bcp.2006.10.001","article-title":"Central alpha1-adrenergic system in behavioral activity and depression","volume":"73","author":"Stone","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0010","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.pbb.2007.02.006","article-title":"Alpha1-adrenergic receptors mediate the locomotor response to systemic administration of (+\/\u2212)-3,4-methylenedioxymethamphetamine (MDMA) in rats","volume":"86","author":"Selken","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0015","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.neuroscience.2007.01.031","article-title":"Changes in adrenoreceptors in the prefrontal cortex of subjects with dementia: evidence of compensatory changes","volume":"146","author":"Szot","year":"2007","journal-title":"Neurosci"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0020","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.JGP.0000237065.78966.1b","article-title":"Aggressive behavior and neuroleptic medication are associated with increased number of alpha1-adrenoceptors in patients with Alzheimer disease","volume":"15","author":"Sharp","year":"2007","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.euroneuro.2004.10.002","article-title":"Antipsychotics lack alpha 1A\/B adrenoceptor subtype selectivity in the rat","volume":"15","author":"Cahir","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0030","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejphar.2006.02.010","article-title":"Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat","volume":"535","author":"Centuri\u00f3n","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0035","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.tips.2004.06.011","article-title":"Update on human alpha1-adrenoceptor subtype signaling and genomic organization","volume":"25","author":"Hawrylyshyn","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0040","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0006-8993(87)90569-5","article-title":"alpha 1-Adrenoceptors in the mammalian brain: similar pharmacology but different distribution in rodents and primates","volume":"419","author":"Palacios","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0006-8993(89)90645-8","article-title":"Characterization of [125I]HEAT binding to alpha 1-receptors in human brain: assessment in aging and Alzheimer's disease","volume":"501","author":"Kalaria","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0014-2999(02)02454-8","article-title":"[11C]RN5: a new agent for the in vivo imaging of myocardial alpha1-adrenoceptors","volume":"453","author":"Matarrese","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0055","first-page":"309","article-title":"A simple automated process for 11C-carboxylation reactions leading to 11C.labelled radiopharmaceuticals in high specific radioactivity","volume":"40","author":"Davenport","year":"1997","journal-title":"J Labelled Cpd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/PL00006665","article-title":"Evaluation of [11C]GB67, a novel radioligand for imaging myocardial alpha 1-adrenoceptors with positron emission tomography","volume":"27","author":"Law","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0065","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0031-6865(99)00032-1","article-title":"Selection, design and evaluation of new radioligands for PET studies of cardiac adrenoceptors","volume":"74","author":"Pike","year":"2000","journal-title":"Pharm Acta Helv"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0070","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/s00259-008-0805-2","article-title":"Quantification of [11C]GB67 binding to cardiac alpha1-adrenoceptors with positron emission tomography: validation in pigs","volume":"35","author":"Park-Holohan","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.nucmedbio.2012.09.010","article-title":"Radiolabelling and PET brain imaging of the \u03b1(1)-adrenoceptor antagonist Lu AE43936","volume":"40","author":"Risgaard","year":"2013","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0080","unstructured":"Jakobsen S, Olsen AK, Nahimi A. Novel synthesis and evaluation of 11C-Corynanathine as alpha-1 adrenergic PET tracer. XI Turku PET symposium 2008, Abstract P41."},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0085","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.nucmedbio.2003.08.012","article-title":"New alpha(1)-adrenoceptor antagonists derived from the antipsychotic sertindole - carbon-11 labelling and PET examination of brain uptake in the cynomolgus monkey","volume":"31","author":"Balle","year":"2004","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0090","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bmc.2012.10.049","article-title":"Discovery of novel \u03b11-adrenoceptor ligands based on the antipsychotic sertindole suitable for labeling as PET ligands","volume":"21","author":"J\u00f8rgensen","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0095","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0968-0896(02)00459-5","article-title":"Synthesis and structure-affinity relationship investigations of 5-aminomethyl and 5-carbamoyl analogues of the antipsychotic sertindole. A new class of selective alpha1 adrenoceptor antagonists","volume":"11","author":"Balle","year":"2003","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/(SICI)1099-1344(20000330)43:4<331::AID-JLCR320>3.0.CO;2-H","article-title":"Improved specific radioactivity of the PET radioligand [11C]FLB 457 by use of the GE medical systems PETtrace MeI microlab","volume":"43","author":"Sandell","year":"2000","journal-title":"Labell Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0105","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00004728-199401000-00023","article-title":"The ECAT EXACT HR: performance of a new high resolution positron scanner","volume":"18","author":"Wienhard","year":"1994","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0110","series-title":"Guide for the care and use of laboratory animals","author":"Clark","year":"1996"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0115","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF02245691","article-title":"PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor","volume":"113","author":"Karlsson","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0120","series-title":"In PET for drug development and evaluation","first-page":"55","author":"Halldin","year":"1995"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0125","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00006231-200504000-00009","volume":"263","author":"Richter","year":"2005","journal-title":"Nucl Med Comm"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0130","doi-asserted-by":"crossref","first-page":"8998","DOI":"10.1002\/anie.200800222","volume":"47","author":"Miller","year":"2008","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0135","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1021\/jm070375w","volume":"50","author":"Wan","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2013.05.007_bb0140","doi-asserted-by":"crossref","first-page":"8343","DOI":"10.1021\/jm200762g","volume":"54","author":"K\u00fcgler","year":"2011","journal-title":"J Med Chem"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805113001108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805113001108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T01:20:51Z","timestamp":1539566451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805113001108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0969805113001108"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2013.05.007","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}